Issues in Healthcare and Pharmacology for Vulnerable Populations

Страна: N/A

Город: N/A

Тезисы до: 01.12.2016

Даты: 01.12.16 — 01.12.16

Е-мейл Оргкомитета:

Организаторы: International Journal of Pharmaceutical and Healthcare Marketing


Vulnerability to health care quality problems can be due to a combination of underlying reasons, including those pertaining to financial circumstances or place of residence; health, age, or functional or developmental status; or ability to communicate effectively. Other personal characteristics, such as race, ethnicity, and sex can also be associated with differential experiences in obtaining quality health care. Furthermore, characteristics of the evolving health system can interact with personal characteristics to contribute to vulnerability. Understanding the underlying sources of vulnerability is critical, not only because of the need to influence the development of targeted quality improvement efforts, but also because addressing the problems vulnerable groups encounter requires coordinated efforts throughout the health system. In particular, populations vulnerable to health care quality problems need to be accounted for in the design of effective systems for health care delivery, the choice of appropriate health care quality measures, and the adaptation of effective communication and education strategies.

Vulnerable populations require special attention in the design of health care quality measurement strategies for three distinct reasons. First, a focus on the quality of care experienced by vulnerable populations could provide new insight into health system problems or identification of problems that otherwise could go undetected. Second, some vulnerable groups are underserved or lack service all together, thus it is important to understand the barriers they face. The same factors that contribute to their vulnerability can also affect their ability to safeguard their own needs and interests adequately. Third, for a variety of technical and other reasons, poor communications with vulnerable populations exasperates the problems.

All papers should look at these vulnerability issues and have a strong marketing or management perspective and will need to make a distinct contribution to the emerging research on the pharmaceutical and healthcare sectors. Empirical research, conceptual papers, literature reviews, case studies, quantitative models, qualitative studies, and pedagogical innovations (syllabus development) are all welcome. Papers can adopt a historical perspective, a current perspective or a future perspective.

Below is a list of topics that are consistent with the scope of the special issue, but other relevant topics are also welcome:
• Ageing population issues
• Healthcare issues in rural areas
• Pharmacology issues in rural areas
• New business models for addressing issues of vulnerable populations
• Disruptive innovations as solutions for vulnerable populations
• Public policy initiatives
• Patient education
• Marketing and communication strategies specific to vulnerable populations


Веб-сайт конференции: